23 305

Cited 20 times in

Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype.

Authors
Song, JH; Ko, KS; Suh, JY; Oh, WS; Kang, CI; Chung, DR; Peck, KR; Lee, NY; Lee, WG
Citation
The Journal of antimicrobial chemotherapy, 61(4):838-844, 2008
Journal Title
The Journal of antimicrobial chemotherapy
ISSN
0305-74531460-2091
Abstract
OBJECTIVES: To investigate the clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype (VanD-vanA VRE). METHODS: We tested in vitro and in vivo efficacies of teicoplanin against VanD-vanA VRE strains. Change in teicoplanin MICs was monitored during incubation with teicoplanin. In vitro and in vivo time-kill assay and survival analysis using a mouse peritonitis model were performed. RESULTS: Teicoplanin MICs of VanD-vanA VRE strains increased to 128 mg/L within 48 h when they were cultured with 120 mg/L teicoplanin. In vitro and in vivo time-kill assay showed that VanD-vanA VRE strains were not eliminated by 120 mg/L teicoplanin in contrast to vancomycin-susceptible E. faecium and VanD-vanB strains. The survival rate of mice infected with VanD-vanA VRE strains treated with teicoplanin was comparable with that of untreated mice. CONCLUSION: Data suggest that teicoplanin would fail in the treatment of VanD type VRE infections if the strains contained the vanA gene, which cannot be detected in the clinical microbiology laboratory.
MeSH terms
AnimalsAnti-Bacterial Agents/pharmacologyAnti-Bacterial Agents/therapeutic use*Bacterial Proteins/genetics*Blood/microbiologyCarbon-Oxygen Ligases/genetics*Colony Count, MicrobialEnterococcus faecium/drug effects*Enterococcus faecium/geneticsEnterococcus faecium/isolation & purificationFemaleGram-Positive Bacterial Infections/drug therapyGram-Positive Bacterial Infections/microbiologyMiceMice, Inbred ICRMicrobial Sensitivity TestsMicrobial ViabilityPeritonitis/drug therapyPeritonitis/microbiologySurvival AnalysisTeicoplanin/pharmacology*Teicoplanin/therapeutic use*Vancomycin Resistance/genetics*
DOI
10.1093/jac/dkn025
PMID
18230690
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Laboratory Medicine
AJOU Authors
이위교
Full Text Link
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse